Skip to main content
Premium Trial:

Request an Annual Quote

Timothy Kennedy

Biocept has appointed Timothy Kennedy as CFO and senior vice president of operations. He succeeds Mark Foletta, who has served as interim CFO since August 2015 and will remain a consultant to the company beginning in September 2016. Kennedy comes to Biocept from Millennium Health, where he served as CFO from 2013 to July 2016. Before his time at Millennium Health, Kennedy served as CFO and general manager of PLUS Diagnostics from 2008 to 2012.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.